Application of multi-technique in combined for the detection and prenatal diagnosis of families affected with Duchenne muscular dystrophy.
10.3760/cma.j.cn511374-20250428-00257
- Author:
Xue ZHANG
1
,
2
;
Ya'na ZHANG
;
Ziye ZENG
;
Qian CHEN
;
Guiming YU
;
Yanling DONG
;
Pu WANG
Author Information
1. Department of Rehabilitation, the First Affiliated Hospital of Army Medical University, Chongqing 400038, China. wangpu_503@
2. com.
- Publication Type:Journal Article
- MeSH:
Humans;
Muscular Dystrophy, Duchenne/diagnosis*;
Prenatal Diagnosis/methods*;
Female;
Male;
Pregnancy;
Pedigree;
Genetic Testing/methods*;
Dystrophin/genetics*;
Adult;
Genetic Counseling;
High-Throughput Nucleotide Sequencing/methods*;
Exons
- From:
Chinese Journal of Medical Genetics
2025;42(10):1160-1167
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To assess the value of combined detection strategies using multiple technologies for the genetic testing and prenatal diagnosis for pedigrees affected with Duchenne muscular dystrophy (DMD) for optimizing genetic counseling and reproductive guidance.
METHODS:This study has involved 142 subjects from 65 suspected DMD families who had visited the First Affiliated Hospital of Chongqing Medical University from January 2018 to December 2023. A combination of multiple ligation-dependent probe amplification (MLPA), quantitative fluorescence PCR, and next-generation sequencing (NGS) was used. After confirming the genetic diagnosis of the probands, prenatal diagnosis was provided for carrier mothers. This study was approved by the Medical Ethics Committee of the hospital (Ethics No.: 2021-264).
RESULTS:Among the 142 subjects tested, 73 cases of large deletions/duplications and 15 cases of small variants of the DMD gene were detected. The hotspot regions for the variants were exons 45 to 55. A total of 41 variant types were identified, of which 3 were previously unreported. In 19 families with suspected patients, 7 exonic deletions, 2 exonic duplications, and 3 small variants were identified. Prenatal diagnosis was performed on 48 fetuses from 46 families, revealing 16 affected male fetuses (including 12 with deletion variants, 2 with duplication variants, and 2 with small variants). Seven carrier females were identified among the 16 female fetuses (including 6 with deletions and 1 with duplication). Among the couples with an affected fetus, 16 had opted to terminate the pregnancy, while the parents of 32 fetuses had chosen to continue with the pregnancy. In families undergoing prenatal diagnosis, 53 (79.1%) pregnant women and their family members were found to carry mutations of the DMD gene.
CONCLUSION:The combined detection strategy of MLPA, qPCR, and NGS can encompass large deletions/duplications and small variants of the DMD gene, providing timely and accurate prenatal diagnosis for families affected by DMD. In conjunction with genetic counseling, this can effectively reduce the risk of producing affected offspring, which is crucial for the prevention and control of this disease.
